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Detecting neurodevelopmental 
trajectories in congenital heart 
diseases with a machine‑learning 
approach
Elisa Cainelli1*, Patrizia S. Bisiacchi1,2*, Paola Cogo3, Massimo Padalino4, 
Manuela Simonato5, Michela Vergine3, Corrado Lanera6 & Luca Vedovelli6
We aimed to delineate the neuropsychological and psychopathological profiles of children with 
congenital heart disease (CHD) and look for associations with clinical parameters. We conducted a 
prospective observational study in children with CHD who underwent cardiac surgery within five 
years of age. At least 18 months after cardiac surgery, we performed an extensive neuropsychological 
(intelligence, language, attention, executive function, memory, social skills) and psychopathological 
assessment, implementing a machine‑learning approach for clustering and influencing variable 
classification. We examined 74 children (37 with CHD and 37 age‑matched controls). Group 
comparisons have shown differences in many domains: intelligence, language, executive skills, and 
memory. From CHD questionnaires, we identified two clinical subtypes of psychopathological profiles: 
a small subgroup with high symptoms of psychopathology and a wider subgroup of patients with 
ADHD‑like profiles. No associations with the considered clinical parameters were found. CHD patients 
are prone to high interindividual variability in neuropsychological and psychological outcomes, 
depending on many factors that are difficult to control and study. Unfortunately, these dysfunctions 
are under‑recognized by clinicians. Given that brain maturation continues through childhood, 
providing a significant window for recovery, there is a need for a lifespan approach to optimize the 
outcome trajectory for patients with CHD.
Congenital heart diseases (CHDs) are the most common congenital defects, affecting nearly 1% of all  newborns1. 
Advances in prenatal diagnosis, perioperative management, and postoperative care have dramatically increased 
the population of CHD survivors. However, CHD patients are at risk of long-term developmental impairments. 
Indeed, the high survival rate of these children into adulthood has determined an alarming prevalence of long-
term  sequelae2.
Recent investigations have shown that even patients with average intelligence and without neuromotor 
impairments may exhibit subtle isolated neuropsychological difficulties and psychological  disorders3,4. These 
impairments and dysfunctions impact one’s social life and academic performance negatively, with long-lasting 
consequences on career and socioeconomic well-being in  adulthood5. However, in clinical practice, these prob-
lems are often underestimated or not promptly recognized.
The underlying pathophysiological mechanism of CHDs is complex and not yet fully understood. It has 
been demonstrated that CHD may interfere with brain development, as reported by several imaging studies 
showing widespread brain abnormalities in CHD term  neonates6. The cardiovascular and nervous systems are 
interconnected and regulate each other during development. Not surprisingly, these systems are functionally 
interconnected in both health and disease.
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This already-complex condition is also influenced by many other variables, such as patient-specific charac-
teristics, potential hypoxic/ischemic cascades triggered by hypoperfusion during cardiac surgery, and pre- and 
postoperative  factors7,8. Furthermore, the effects of early exposure to stressful environments and dysfunctional 
parental attitudes associated with a child’s medical illness may be additional risk factors, arguments thoroughly 
discussed in other medical contexts (for example,  see9).
Unfortunately, we lack precise prognostic tools in terms of CHD; some biomarkers appear  promising7,10,11, 
and CHD severity has been generally associated with an increased incidence of impairments, but studies do not 
completely  agree2,12. The impact of medical factors on developmental trajectories have not been well explored 
yet, and only a few data on specific CHD populations are  available3,13.
In this study, we performed a neuropsychological and psychopathological assessment of children with CHD, 
comparing their performances with those of age-matched control children. We implemented a machine-learning 
approach to identify and rank the most important parameters that differentiated the two groups. To identify 
disease subtypes, we also performed a cluster analysis to divide individual CHD patients into homogenous 
subgroups based on psychological profiles. Finally, we looked for an association of psychological outcomes with 
several medical parameters.
Patients’ selection was unrelated to CHD type; selection was only based on the patients’ age at recruitment 
to increase the generalizability of results across heart defects (Table 1).
Results
Descriptive results. At the time of the study, 75 children were eligible; 20/75 were lost at follow up or 
declined to participate, 6/75 were excluded because they did not speak Italian, and 7/75 because of medical 
comorbidities; finally, 3/42 did not attend all scheduled meetings and therefore did not complete evaluations, 
and 2/42 additional patients were excluded because of IQ (< 70). Of the 38 children not included in the study, 6 
(15%) was STAT 1, 15 (39%) STAT 2, 8 (21%) STAT 3, 6 (15%) STAT 4, 3 (7%) STAT 5.
The final sample population consisted of 37 patients (median age 7.41, 5.53–7.91 years, males 21, 57%).
We recruited 34 healthy children (from here, called “controls “) (median age 7.25, 6.00–8.25 years, males 12, 
35%). From the comparison of neuropsychological scores, 3 CHD children and one control child were excluded 
because of missing data. Cluster analysis was performed on 34 CHD children for the same reason.
Five CHD patients obtained borderline IQ scores (70 ≥ IQ < 85); all other CHD children demonstrated IQs 
in the average range. All control children demonstrated IQs in the average range.
Details on cognitive and neuropsychological results in both groups are shown in Table 2.
Details on psychopathological scores in all domains are shown in Tables 3 and 4.
Compared results of neuropsychological and psychopathological scores are reported in Tables 2, 3, and 4.
Machine‑learning features selection. After an initial screening and comparison between CHD patients 
and controls, we used a machine-learning algorithm (Boruta) to find the most influential features distinguish-
ing CHD patients from controls. The algorithm gave an overall index of the importance of each variable with its 
respective standard errors and a dichotomic evaluation of “important “ or “not important.“ Results are depicted 
in Fig.  1 for both neuropsychology and psychopathology. We found that the variables most effective in dif-
ferentiation were (in order of importance) semantic fluency, auditory attention, and visual memory for neu-
ropsychology (Fig. 1a) and thought problems, anxiety/depression, aggressive behavior, and attention problems 
for symptoms of psychopathology (Fig. 1b). Other important variables are shown (ordered) in Fig. 1. The full 
variable table is reported in Supplementary Materials’ Tables S1 and S2.
Table 1.  Clinical characteristics of the CHD population. Continuous variables are expressed as 
mean ± standard deviations (range min–max). STAT: The Society of Thoracic Surgeons-European Association 
for Cardio-Thoracic Surgery score CPB: cardiopulmonary bypass.







Age at surgery (months) 15.2 ± 20.3 (0–66)
Pre-surgery oxygen saturation (%) 90.44 ± 7.41 (74.0–100)
Temperature nadir (°C) 30.2 ± 3.9 (18.0–35.3)
CPB time (min) 127 ± 49.6 (50–250)
CPB time with cerebral saturation < 45% (%) 19.4 ± 27.8 (0–100)
Arterial plasma lactates (mmol/L) 2.6 ± 1.5 (0.9–6.9)
Intensive care unit stay (days) 6.6 ± 10.7 (1–62)
Prematurity, n (%) 2 (5%)
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Cluster analysis. Neuropsychology (NPS). Cluster analysis revealed that three clusters explained 55.49% 
of the point variability of performance at neuropsychological tasks. We evaluated the clusters and determined 
that the three clusters could be described as follows: The first cluster (Impaired NPS Functioning), accounting 
for 26% of the sample, exhibited several impairments, particularly in IQ, executive functions, and social skills. 
The second cluster (Typical NPS Functioning), accounting for 59% of the sample, exhibited average scores in 
all domains. The third cluster (Good NPS Performance), 15% of the sample, exhibited good performance, par-
ticularly in IQ, executive functions, and social skills. The pattern of neuropsychological deficits can be seen in 
Fig. 2. Numerical data and clinical variable comparisons among clusters are reported in Supplementary Table S2.
Symptoms of psychopathology (PSY). Cluster analysis revealed that three clusters explained 59.02% of the point 
variability of performance on psychopathological questionnaires. We evaluated the clusters and determined that 
they could be described as follows: The first cluster (Attention Deficit Hyperactivity Disorder—ADHD), 41% 
of the sample, exhibited increased inattention, hyperactivity, and impulsivity scores. The second cluster (Global 
Pathological PSY), 12% of the sample, exhibited clinically relevant scores in most domains. The third cluster 
(Adequate PSY Functioning), 47% of the sample, exhibited adequate scores in all domains. The pattern of psy-
chopathological scores can be seen in Fig. 3.
The combination of the cluster analyses of neuropsychological and psychopathological scores shows that 
31% of patients had no problems and belonged to the clusters designated Typical NPS (23%) or Good NPS 
Performance (8%) and Adequate PSY Functioning; however, 26% of patients belonged to Typical NPS Func-
tioning but had ADHD, and 8% belonged to Global Pathological PSY; 5% belonged to Good NPS Performance 
but had ADHD. Finally, 14% exhibited Impaired NPS Functioning alone, 8% with additional ADHD, and 2% 
with additional Global Pathological PSY. Numerical data and clinical variable comparisons among clusters are 
reported in Supplementary Table S2.
Correlation with medical parameters. No significant correlations were found between neuropsycho-
logical and psychopathological tasks with clinical parameters in CHD children. No differences in clinical param-
eters were found between the clusters (Tables S2 and S3).
Table 2.  Median and mean cognitive and neuropsychological scores obtained by the control and CHD groups.
Domain Test Controls (N = 33) CHD (N = 35) Adjusted P value
General intelligence
QI 0.041
Median (Q1,Q3) 105 (101, 116) 99 (89.5, 110)
Language
Naming 0.026
Median (Q1,Q3) 0.1 (0.0, 0.7) − 0.3 (-0.7, 0.2)
Attention
Visual attention 0.242
Median (Q1,Q3) 11.0 (10.0, 12.0) 10.5 (8.0, 12.0)









Median (Q1,Q3) 10.0 (9.0, 13.0) 9.0 (7.0, 11.0)
Digit span 0.066
Median (Q1,Q3) 10.0 (9.0, 11.0) 8.0 (7.0, 11.5)
Semantic fluency  < 0.001
Median (Q1,Q3) − 0.3 (-0.8, 0.6) − 1.4 (− 2.1, − 0.7)
Memory
Visual memory 0.026
Median (Q1,Q3) 10.0 (10.0, 11.0) 9.0 (6.0, 10.0)
Social skills
Theory of mind A 0.890
Median (Q1,Q3) 0.1 (− 0.6, 1.0) 0.3 (− 0.5, 0.9)
Theory of mind B 0.242
Median (Q1,Q3) 0.1 (− 0.3, 0.5) − 0.4 (− 0.9, 0.8)
Theory of mind T 0.585
Median (Q1,Q3) 10.0 (8.0, 12.0) 10.0 (8.0, 11.5)
Affect recognition 0.190
Median (Q1,Q3) 10.0 (9.0, 11.0) 9.0 (4.5, 11.0)
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Discussion
Our study highlights that CHD survivors, even in the absence of severe disabilities, are at high risk of developing 
a broad range of neuropsychological and psychopathological dysfunctions. Our purpose was to look for clinically 
pathological conditions as well as subclinical vulnerabilities, which may emerge from comparison with healthy 
controls. For a clearer look at the importance of each variable in determining the CHD profile, we implemented 
a robust machine-learning algorithm to classify variables based on their ability to distinguish CHD patients 
from controls. We found that the variables presenting the greatest differences were (in order of importance) 
semantic fluency, auditory attention, and visual memory for neuropsychology and thought problems, anxiety/
depression, aggressive behavior, and attention problems for the symptoms of psychopathology. To understand 
trends related to neuropsychological and psychopathological functioning in the CHD group, we looked for 
specific homogeneous subtypes using unsupervised, machine learning-based cluster analysis. Interestingly, the 
neuropsychological tests that differentiated between the groups (CHD vs controls) more effectively were those 
that did not differentiate between the clusters. The dysfunctions in these neuropsychological abilities probably 
represent a common core, while the trend of the three clusters highlights additional variability.
Finally, neither the mean scores nor the clusters appeared influenced or differentiated by the clinical param-
eters that we selected to account for the perioperative period (pre-, intra-, and post-surgery). One of the strengths 
of our study is that because a small sample size could be a source of biased analyses, we defined the analysis 
pipeline a priori and followed it thoroughly. We used a robust, adjusted nonparametric univariate comparison 
as a first screening of the data to show differences between the CHD patients and controls. The second step was 
to define which variables were more important to differentiate the groups. To accomplish this task, we used a 
random forest approach, an ensemble machine-learning method in which multiple independent decision trees 
are combined to get better predictions. Trees are constructed by randomizing data and variables to obtain the 
lowest possible correlation among them. The strength of a random forest approach is that it is insensitive to 
initial correlations among variables (a common problem in every set of psychological evaluation items). Finally, 
to determine CHD profile clusters, we used a robust clustering approach based on medoids (partitioning around 
medoids, PAM), in which every cluster is defined after the selection of a representative case. This approach is 
much less sensitive to influential cases than traditional partitioning methods, such as k-means clustering.
Table 3.  CBCL Median and mean scores in the control and CHD groups.
CBCL subscales Controls (N = 34) CHD (N = 37) Adjusted P value
Withdrawal 0.006
Median (Q1,Q3) 50.0 (46.0, 52.0) 52.0 (50.0, 59.5)
Mean 50.1 (8.6) 55.0 (6.6)
Somatic complaints 0.007
Median (Q1,Q3) 50.0 (50.0, 51.0) 53.0 (50.0, 58.0)
Mean 51.6 (9.2) 56.1 (7.5)
Anxiety/depression  < 0.001
Median (Q1,Q3) 50.0 (47.0, 50.8) 52.0 (51.0, 60.5)
Mean 50.1 (8.1) 55.2 (6.7)
Social problems 0.076
Median (Q1,Q3) 51.0 (50.0, 56.0) 52.0 (51.0, 58.0)
Mean 51.6 (8.3) 54.5 (5.1)
Thought problems 0.008
Median (Q1,Q3) 47.0 (46.0, 51.0) 51.0 (50.0, 56.0)
Mean 50.7 (6.1) 54.2 (6.3)
Attention problems  < 0.001
Median (Q1,Q3) 50.0 (45.2, 51.0) 53.0 (50.0, 63.5)
Mean 49.8 (7.0) 57.1 (7.8)
Rule breaking 0.049
Median (Q1,Q3) 50.0 (43.2, 55.0) 52.0 (50.0, 56.0)
Mean 50.3 (7.7) 53.7 (5.1)
Aggressive behavior 0.002
Median (Q1,Q3) 50.0 (45.0, 50.8) 51.0 (50.0, 56.0)
Mean 48.6 (6.5) 54.4 (8.1)
Internalizing 0.014
Median (Q1,Q3) 44.0 (40.2, 49.8) 49.5 (45.2, 61.5)
Mean 45.7 (10.5) 52.3 (12.1)
Externalizing 0.008
Median (Q1,Q3) 43.0 (38.2, 50.0) 50.0 (44.0, 56.0)
Mean 44.6 (8.3) 50.8 (10.8)
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Besides clinically significant impairments, the group comparisons (CHD patients vs controls) highlighted 
significant differences in several domains: intelligence, language, executive skills, and memory. This intrinsic 
weakness in the neuropsychological performance of CHD patients was confirmed by variable classification and 
clustering, which established a subgroup of children with low performance, mostly in intelligence, executive 
functioning, and social skills. Similarly, comparing the groups’ psychopathological scores showed that CHD 
patients performed worse in many psychological domains. Despite the significant differences, all mean CHD 
scores were still within the average range in terms of population norms. One reason may be that a healthy control 
group of typically developing children, growing up in the same period, may offer a more representative reflec-
tion of normal variation. Another reason may be that the group’s comparisons allow us to highlight subclinical 
vulnerabilities. A similar condition may be a predisposition to some personal weaknesses and remain unchanged 
or get worse over time, as more complex abilities emerge and the cumulative effects of several risk factors act 
synergistically.
Table 4.  CRS-R Median and mean scores in the two groups are reported. ADHD: attention deficit 
hyperactivity disorder; CGI: clinical global index; DSM: diagnostic and statistical manual of mental disorders.
CRS-R subscales Controls (N = 34) CHD (N = 37) Adjusted P value
Oppositional 0.286
Median (Q1,Q3) 45.0 (40.0, 50.0) 47.5 (43.0, 55.0)
Mean 46.1 (7.3) 51.0 (13.1)
Cognitive problems 0.286
Median (Q1,Q3) 44.5 (41.2, 50.0) 48.5 (43.0, 54.8)
Mean 48.1 (9.7) 52.1 (12.4)
Hyperactivity-impulsivity 0.094
Median (Q1,Q3) 42.5 (40.0, 45.8) 49.5 (41.2, 56.0)
Mean 44.0 (5.7) 51.3 (11.5)
Anxious-shy 0.676
Median (Q1,Q3) 44.0 (39.0, 50.8) 47.0 (40.0, 52.5)
Mean 46.3 (8.3) 48.1 (11.3)
Perfectionism 0.290
Median (Q1,Q3) 41.5 (38.5, 49.0) 46.0 (40.0, 52.0)
Mean 44.4 (7.9) 47.8 (11.3)
Social problems 0.623
Median (Q1,Q3) 44.0 (43.0, 49.0) 44.0 (43.0, 47.8)
Mean 47.3 (6.8) 47.2 (9.2)
Psychosomatic 0.290
Median (Q1,Q3) 44.0 (42.2, 50.0) 44.0 (43.0, 57.2)
Mean 46.3 (4.8) 52.1 (14.4)
ADHD Index 0.269
Median (Q1,Q3) 44.5 (40.0, 56.0) 49.0 (42.2, 60.0)
Mean 48.3 (10.1) 52.6 (12.5)
CGI: hyperactivity-imp 0.136
Median (Q1,Q3) 44.5 (40.2, 49.8) 50.0 (42.0, 60.8)
Mean 46.1 (8.3) 52.3 (12.5)
CGI: emotional instability 0.442
Median (Q1,Q3) 42.0 (41.0, 47.0) 42.0 (41.0, 53.2)
Mean 44.4 (6.0) 49.3 (13.4)
CGI: total 0.190
Median (Q1,Q3) 43.5 (39.0, 47.0) 47.0 (41.0, 59.8)
Mean 44.9 (7.7) 51.3 (13.7)
DSM IV: inattentive 0.351
Median (Q1,Q3) 45.5 (42.0, 55.8) 47.0 (42.5, 57.2)
Mean 48.6 (9.5) 52.1 (12.2)
DSM IV: hyperactivity-imp 0.136
Median (Q1,Q3) 43.0 (41.0, 49.8) 49.0 (42.0, 60.5)
Mean 44.5 (6.5) 51.2 (11.3)
DSM IV: total 0.269
Median (Q1,Q3) 43.5 (41.0, 51.5) 48.5 (41.5, 61.5)
Mean 46.4 (8.1) 51.5 (12.2)
6
Vol:.(1234567890)
Scientific Reports |         (2021) 11:2574  | https://doi.org/10.1038/s41598-021-82328-8
www.nature.com/scientificreports/
High rates of psychopathological symptoms have been reported in CHD  patients14. In our study, we found two 
clinical subtypes of psychopathological profiles: a small subgroup with high symptoms of psychopathology (i.e., 
widespread clinical elevations in many areas of psychological functioning) and a wider subgroup of patients with 
ADHD-like profiles, with hyperactivity and impulsivity symptoms as the most represented. ADHD is a disorder 
associated with white matter injuries, which are typically reported in CHD  neonates15. It is interesting to note 
the differences in studies on children born premature, in whom similar patterns of white matter dysmaturity at 
birth have been reported (for a review,  see15). Premature children are at high risk of developing ADHD, but the 
inattentive ADHD subtype has been shown as  typical16. It is possible that environmental factors impact CHD 
patients more strongly; compared to premature children, who experience intensive care mostly at birth, CHD 
children could experience repeated hospitalizations, medical procedures, and follow-up visits throughout child-
hood. Thus, parent–child interactions may be challenged by repeated exposure to high-risk medical conditions, 
inducing chronic stress, and less adaptive coping mechanisms, such as overprotective attitudes.
However, contextual factors may not be the sole cause. Among pediatric populations with chronic diseases, 
CHD patients display higher frequencies of lifetime psychiatric disorders (i.e., 65% vs 56% of childhood cancer 
Figure 1.  We applied the machine-learning algorithm (Boruta) to find the most influential features that 
distinguish between CHD patients and controls in neuropsychology (Panel a) and symptoms related to 
psychopathological (Panel b) functioning. The algorithm gives an overall index of the importance of each 
variable with their respective standard errors and a dichotomic evaluation of “important “ (green boxes) or “not 
important “ (red boxes). The solid black line represents the mean, the box edges are the first and third quartiles, 
and the circles are outliers, defined as outside 1.5 times the interquartile range (whiskers) above the upper 
quartile and below the lower quartile.
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Figure 2.  The pattern of neuropsychological functioning obtained through the cluster analysis. The three 
clusters are represented in three colors (red, green, and blue). The standardized value of each variable is depicted 
as a boxplot for each cluster. The solid black line represents the mean, the box edges are the first and third 
quartiles, and the circles are outliers, defined as outside 1.5 times the interquartile range (whiskers) above the 
upper quartile and below the lower quartile.
Figure 3.  The pattern of psychopathological functioning obtained with the cluster analysis. The three clusters 
are represented in three colors (red, green, and blue). The standardized value of each variable is depicted as a 
boxplot for each cluster. The solid black line represents the mean, the box edges are the first and third quartiles, 
and circles are outliers, defined as outside 1.5 times the interquartile range (whiskers) above the upper quartile 
and below the lower quartile.
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survivors)17. Therefore, the impact of CHD on cerebral circuitries underlying psychopathological vulnerability 
might be considerable.
The brain develops rapidly in the third trimester and throughout the early postnatal months. During this 
period, CHD infants are at risk of exposure to hypoxia, neuroinflammation, stress, and clinical procedures requir-
ing general anesthesia. In those children, early structural and microstructural brain abnormalities are already 
evident in the neonatal period. The mechanism is not well understood, but chronic hypoxia—an effect of some 
CHDs—could prompt a maturational arrest of oligodendrocyte progenitors, leading to delayed myelination. This 
abnormal myelination may disrupt neuronal network development via several mechanisms (for a review,  see15. 
Subsequently, cardiac surgery may introduce additional risk factors. Such early perturbations of the development 
of neuronal networks, if sustained, may be responsible for the persistent neurocognitive impairment reported 
in survivors of CHD. Some late-emerging circuits, particularly in the frontal-subcortical area, have a crucial 
role in high cognitive functions and psychological  abilities18, as well as neurologic conditions with psychiatric 
manifestations (for  example19).
The heterogeneity of environmental circumstances and differences in the timing of stressful events may 
explain the broad spectrum of behavioral and psychological symptoms observed in this study’s participants. It has 
been estimated that known risk factors explain only about 30% of the observed variation in neurodevelopmental 
outcomes after cardiac surgery in  infancy3. Interestingly, we did not find medical determinants for our outcomes. 
To our knowledge, only a few studies focused on specific CHD subgroups have reported associations between 
neuropsychology/psychopathology and medical or perioperative  variables3,12,13. It is interesting that the role of 
medical factors has been so poorly explored in neuropsychological and psychopathological research; there may 
be an underrepresentation due to the trend to report only positive findings.
In fact, while it is relatively simple to find an association between some medical variables and dichotomous 
outcome scores, as also reported by our previous  works7,11, it is challenging to find it related to specific neu-
ropsychological or psychological functions. The developmental trajectories of high-order functions depend on 
many unpredictable variables, which are strictly interconnected with each other. Individual characteristics, such 
as genetics, temperament, and specific vulnerability to some impairments or problems, interact with parental 
variables and illness, hospitalization, and medical procedures. The further we move away from basic cognitive 
functions, the harder it becomes to find a unique, organic counterpart.
Furthermore, cognition and personality take several years to develop; cumulating effects may take several 
years to become evident. For this reason, outcomes are highly variable, depending on various factors and tim-
ing—there may be a point at which intervention procedures are no longer effective. However, it is not currently 
understood why some children manifest some symptoms but not others, and how or whether this relates to the 
developmental time course. Developmental pathways may assume peculiar trajectories, resulting in the high 
interindividual variability characterizing patients with CHD and other neurological diseases. In our study, inter-
individual variability manifests itself in highly variable scores in neuropsychological tasks or psychopathological 
questionnaires, a trend illustrated by the clusters. High interindividual variability may be seen as a methodo-
logical limitation, accounting for the differences in the results of many studies, or as a result of the illness itself. 
Individuals are remarkably diverse, exhibiting variation across a host of behaviors and phenotypes—this is true 
in typical development, but even more so in atypical development. Furthermore, it confirms the importance of 
researching early prognostic indicators, as in other pathological  conditions20.
Our findings should be interpreted in light of potential limiting factors. First, the sample size is small, and 
even with all the precautions we enacted, this could limit the generalization of our results. Moreover, there is an 
imbalance in sex between the groups. Therefore, our data should be considered preliminary, and future research 
should confirm our results.
Regarding the assessment, we did not investigate parental mental states, known to potentially bias assessments 
of children’s health. Further, an in-depth investigation of psychopathological profiles (based in the present work 
only on parent ratings) and executive functions could have determined a major understanding of our results.
Finally, our sample covers a broad range of ages. At these ages, executive functioning develops suddenly, 
new skills emerge, and consequently, the evaluation tasks change substantially for tasks measuring the same 
executive subcomponents. For this reason, we chose to test “basic “ executive functions, which are relatively 
mature at an early age.
In conclusion, results on neuropsychological and psychological aspects suggest that a complex framework of 
cerebral dysfunctions affects children with CHD. Our data are preliminary and should be confirmed by further 
research with larger samples. The issue deserves attention because childhood neuropsychological and psychologi-
cal problems may not be present as focused disorders, and therefore, they might be under-recognized. Patients 
at risk are often identified late because neuropsychological deficits have remained unidentified or unspecified 
after leading to academic problems. Furthermore, cognitive aspects and medical-clinical characteristics may 
not fit together in the same puzzle. Causative mechanisms for adverse neurocognitive outcomes are multifacto-
rial, interrelated, cumulative, and likely synergistic over time. Brain maturation, including the refinement of 
brain networks and myelination, continues through childhood, providing a significant window for recovery 
and highlighting the need for a lifespan approach to optimizing the outcome trajectory for patients with CHDs. 
Detailed clinical evaluations focusing on neuropsychological and psychological aspects are a promising path to 
new neurological and neurobiological research.
Methods
Participants. This was a prospective, observational, single-center study of children with CHD. The study 
was approved by the Institutional Review Board and Ethics Committee, Padova University Hospital, and per-
formed in accordance with relevant regulations. Written informed consent for participation and publication was 
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obtained. Inclusion criteria were: children with complex CHD requiring surgical repair with cardiopulmonary 
bypass (> 50 min) and hypothermia; elective cardiac surgery, spontaneous breathing, and stable hemodynamic 
conditions (constant inotropic support if needed, no volume load at admission or during the presurgical hospital 
stay) before surgery; good Italian linguistic skills; at least 4 years of age; and 18 months from surgery to allow 
a full recovery. Exclusion criteria included age at surgery > 5 years, liver disease (defined as coagulation factor 
V < 20%), kidney failure (creatinine clearance < 30%), or known chromosomal abnormalities.
We collected demographic and clinical outcome data prospectively (Table 1). Surgical procedures for CHD 
repair were classified according to The Society of Thoracic Surgeons-European Association for Cardio-Thoracic 
Surgery (STAT)  scores21.
The patients’ clinical characteristics are reported in Table 1.
The controls were recruited in a primary school. The project was presented and asked which families wanted 
to join freely.
Outcome assessment. We measured general intelligence using the Wechsler Preschool and Primary Scale 
of Intelligence III (WPPSI-III22) test or the Wechsler Intelligence Scale for Children IV (WISC-IV23).
We used the naming test for  language24; for attention, the visual and auditory attention tests of the NEPSY-
II25; for memory, the design memory test of the NEPSY-II25, which evaluates short-term visuospatial memory; 
to evaluate executive functions, the coding test of the WISC-IV or WPPSI-III22,23, the semantic verbal fluency 
test, which evaluates the ability to access the lexicon through a categorical  cue24, and the digit span test of the 
WISC-IV or WPPSI-III22,23, which evaluates working memory; and for social skills, the theory of mind A and B 
and affect recognition tests of the NEPSY-II25.
Detailed descriptions of the tests and procedures are reported in the supplemental material (Table S5).
Parents compiled the following psychopathological questionnaires:
Child behavior checklist (CBCL)26 The CBCL is a multiaxial, empirically based set of measures assessing a 
child ‘s emotional, behavioral, and social problems over the past six months.
Conners’ rating scales-revised (CRS-R)27 CPRS-R:L reports parent ratings of children’s behaviors involving 
problems in seven psychopathological areas: oppositional, inattention, hyperactive, anxious–shy, perfection-
ism, social problems, and psychosomatic.
Statistical analysis. Data were expressed as mean (SD), median (Q1-Q3), or percentages. We used a non-
parametric Kruskal–Wallis test for patient-control comparisons of continuous variables, and Fisher’s exact test 
for categorical variables. We used an Armitage trend test for ordered categorical variables. Feature selection 
relied on a machine-learning algorithm based on random forest (Boruta); the Boruta algorithm aims to iden-
tify the relevant predictors that impact the outcome of interest (in our case, belonging to the CHD or control 
group). It implements a random forest on an augmented set of covariates. Additional covariates, called shadow 
variables, are copies of the original ones obtained by permuting the observations and thus removing the even-
tual association with the outcome. For each explanatory variable, an importance measure is computed (i.e., 
the Z-score), which is the average improvement in the predictive performance of the random forest with the 
considered explanatory variable divided by its standard deviation. The obtained important predictors are those 
that show Z-scores higher than the one observed for the variable with the maximum Z-score among the shadow 
variables. The procedure is repeated until an importance measure is assigned to each predictor or the maximum 
number of random forests is reached. We used the {Boruta} R  package28 for the analysis. Moreover, to identify 
underlying homogeneous clusters of CHD patients, we used a robust unsupervised clustering algorithm (PAM) 
using the {cluster} R package. Included variables of neuropsychology were standardized (Z-scores) and centered 
before clustering because they were on different scales. The best number of clusters was determined to compare 
the results of 30 indices with the {NbClus} R  package29. Variables included for clustering were all the neuropsy-
chology and symptoms of psychopathology parameters except for the “total “ variables to avoid overinflation 
of single-test sections. We evaluated clinical parameters’ simple linear correlations with neuropsychology and 
symptoms of psychopathology parameters according to Spearman and corrected multiple comparisons for false 
discovery rates using the Benjamini–Hochberg method. We used R software v. 4.0 for the analysis and graphics.
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author on reasonable request.
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